Prospective comparison of novel dark blood late gadolinium enhancement with conventional bright blood imaging for the detection of scar by Francis, R et al.
RESEARCH Open Access
Prospective comparison of novel dark
blood late gadolinium enhancement with
conventional bright blood imaging for the
detection of scar
Rohin Francis1,2, Peter Kellman3, Tushar Kotecha4,5,1, Andrea Baggiano4,1, Karl Norrington4,1,
Ana Martinez-Naharro4,1, Sabrina Nordin5,1, Daniel S. Knight1,5, Roby D. Rakhit5, Tim Lockie5, Philip N. Hawkins4,
James C. Moon6, Derek J. Hausenloy2,6,7,8,9,10, Hui Xue3, Michael S. Hansen3 and Marianna Fontana4,1*
Abstract
Background: Conventional bright blood late gadolinium enhancement (bright blood LGE) imaging is a
routine cardiovascular magnetic resonance (CMR) technique offering excellent contrast between areas of LGE
and normal myocardium. However, contrast between LGE and blood is frequently poor. Dark blood LGE (DB
LGE) employs an inversion recovery T2 preparation to suppress the blood pool, thereby increasing the contrast between
the endocardium and blood. The objective of this study is to compare the diagnostic utility of a novel DB phase sensitive
inversion recovery (PSIR) LGE CMR sequence to standard bright blood PSIR LGE.
Methods: One hundred seventy-two patients referred for clinical CMR were scanned. A full left ventricle short axis stack
was performed using both techniques, varying which was performed first in a 1:1 ratio. Two experienced observers
analyzed all bright blood LGE and DB LGE stacks, which were randomized and anonymized. A scoring system was
devised to quantify the presence and extent of gadolinium enhancement and the confidence with which the diagnosis
could be made.
Results: A total of 2752 LV segments were analyzed. There was very good inter-observer correlation for quantifying LGE.
DB LGE analysis found 41.5% more segments that exhibited hyperenhancement in comparison to bright blood LGE (248/
2752 segments (9.0%) positive for LGE with bright blood; 351/2752 segments (12.8%) positive for LGE with DB; p < 0.05).
DB LGE also allowed observers to be more confident when diagnosing LGE (bright blood LGE high confidence in 154/
248 regions (62.1%); DB LGE in 275/324 (84.9%) regions (p < 0.05)). Eighteen patients with no bright blood LGE were
found to have had DB LGE, 15 of whom had no known history of myocardial infarction.
Conclusions: DB LGE significantly increases LGE detection compared to standard bright blood LGE. It also increases
observer confidence, particularly for subendocardial LGE, which may have important clinical implications.
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Background
Conventional bright blood late gadolinium enhancement
(LGE) cardiovascular magnetic resonance (CMR) imaging
offers excellent contrast between areas of bright LGE and
normal myocardium, which is dark. However, contrast
between myocardial gadolinium and the bright blood pool
is frequently poor, meaning subendocardial LGE may be
missed [1]. Infarct size is a key determinant of prognosis
following a myocardial infarction (MI) [2] and a reduction
in CMR-derived infarct size is a common surrogate end-
point in clinical trials [3, 4] and can guide therapeutic
decisions [5]. The presence and characteristics of LGE in
non-ischemic disease processes, such as hypertrophic
cardiomyopathy, dilated cardiomyopathy or cardiac amyl-
oidosis, also confer important diagnostic and prognostic
information [6–8]. Detecting the presence and extent of
LGE is therefore of major importance.
A large proportion of MIs are sub-endocardial and
thus adjacent to the blood pool. The contrast between
the blood and the MI in the inversion recovery (IR)
image depends on variables such as contrast agent
dosage, time from gadolinium administration, clearance
rate and imaging parameters. Blood velocity may also
have a role in the contrast, even though non-slice-
selective IR is used. Therefore, as a result of mechanisms
that are not fully characterized or controlled, it is not
infrequent that subendocardial MIs are difficult to detect
or clearly delineate.
Imaging at a later time point can result in better blood
pool contrast for some subjects, but it may not be
practical from the standpoint of clinical workflow to
delay imaging, and in some instances contrast may
worsen. Technical solutions to this problem are to use
multiple contrasts such as T1 and T2 [1, 9], or to use
blood suppression techniques [10–15]. The T2 of blood
(250 ms) is significantly longer than that of myocardium
(45 ms) and may be used to discriminate the MI from
blood pool. In the “Multi-contrast delayed enhance-
ment” (MCODE) approach [1, 16, 17], both T1- and T2-
weighted images are acquired within the same breath-
hold. The T1-weighted image is a phase sensitive inver-
sion recovery (PSIR) image, and the T2-weighted image
uses a radiofrequency (RF) preparation for T2-weighting.
Both images are acquired at the same diastolic cardiac
phase and are spatially registered facilitating fusion of
the images to enhance the subendocardial border.
An alternative approach that also exploits the differ-
ence in tissue T1 and T2 is to use a segmented cine IR
with balanced steady state free precession (bSSFP) read-
out [9]. In this method, each cardiac phase has a unique
T1 and T2 contrast as determined by both the inversion
recovery and the bSSFP readout which has a √(T2/T1)
steady state dependence. The blood will appear dark at a
different cardiac phase than the MI. In an alternative
approach an IR fast low angle shot (FLASH) sequence
may be modified to null both the blood and the normal
myocardium using 2 inversions with carefully chosen in-
version times [10, 18]. These methods achieve suppres-
sion of blood at the price of signal-to-noise ratio (SNR)
and largely rely on the T1 of scar being shorter than
blood. It has recently been shown that PSIR imaging
with a shorter inversion time set to null the blood may
also be used to improve the contrast between the MI
and adjacent blood pool signal without requiring a spe-
cial RF preparation [19].
Alternatively, LGE with blood suppression may be
achieved my combining either a T2 preparation [12,
14] with IR or by combining a magnetization transfer
(MT) preparation with IR [11, 13]. In these schemes,
the myocardial signal is reduced relative to the blood
signal thereby reducing the inversion time to null the
myocardium. In this way, it is possible to null both
the myocardium and the blood at the same time. The
order of the T2 and IR preparations may be applied
as T2-IR [12] or IR-T2 [14]. Both of these previously
reported schemes used a FLASH readout. In this
present work [15], we combined an IR-T2 with a sin-
gle shot bSSFP readout and respiratory motion cor-
rected averaging [16, 20, 21] to achieve the acceptable
SNR while maintaining the desired spatial and tem-
poral resolution. In this manner, imaging is conducted
free-breathing which has benefits for image quality,
patient comfort, and clinical workflow in both adults
[22] and children [23]. Furthermore, by using a PSIR
reconstruction [24] the blood signal may be made
darker than the myocardium (i.e., negative signal
values) thereby providing contrast between the blood
and both the MI and remote myocardium [15].
Free-breathing, motion-corrected (MOCO) bright
blood LGE has been demonstrated to be comparable
to breath-held sequences and offers particular advan-
tages in terms of patient comfort, image quality and
clinical workflow [22]. This study sought to determine
whether DB LGE could detect more scar and/or in-
crease both inter-observer variability, compared to
conventional PSIR LGE imaging. CMR imaging,
initially validated against histology in the seminal
work done by Kim et al., has become a widely
accepted component of a standard clinical scan [25]
although most institutions are not using the specific
imaging protocol that was validated [26]. As the
clinical utility of bright blood LGE has widened, a
degree of variation in the technique’s application has
been introduced; such as lower gadolinium dose,
MOCO, new image reconstruction techniques such
PSIR, and the proposed DB LGE, which although not
histologically validated, have been shown to provide
clear benefits.
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Methods
A total of 172 adult patients referred for clinical CMR
were scanned using a 1.5 T scanner (Magnetom Aera,
Siemens Healthineers, Erlangen, Germany). All ethics
were approved by the local ethics committee and all par-
ticipants provided written informed consent.
Indications for CMR were a typical case-mix for a clin-
ical CMR center. After standard clinical scan sequences
(pilots, transverse white and black blood images, cines
images to assess left ventricular volumes and mass), a
full short axis stack of bright blood LGE and DB LGE
images were acquired approximately between 8 and
15 min after the administration of contrast agent (Gado-
terate meglumine, 0.1 mmol/kg). This dose reflects local
protocol, which is the current clinical standard in other
centers as well [8, 27–30]. All LGE imaging was acquired
free-breathing with MOCO and was reconstructed using
PSIR. Patients were assigned to undergo either first re-
ceive bright blood LGE or DB LGE sequences in a 1:1
ratio. The duration of the acquisition for the bright
blood LGE approach was 16 heart beats per slice (8
measurements × 2 RR) and for the DB LGE approach
was 32 heart beats (16 measurements), with an add-
itional T1 map for determination of inversion and T2
preparation time parameters [15].
LGE image acquisition
Both DB LGE and bright blood PSIR LGE images were
acquired free-breathing using a single shot bSSFP se-
quence with MOCO averaging of repeated measure-
ments [15, 16]. The single-shot bSSFP sequence, rather
than breath-held segmented gradient echo (GRE) was
used so that PSIR bright blood LGE would be free-
breathing for both protocols being compared. Free-
breathing LGE is becoming widely used to avoid artifacts
due to poor breath-holding and irregular rhythm, and is
used by default at our institution on all patients.
DB LGE images were acquired with parameters
matched to the bright blood LGE images except for the
TI. DB LGE images were implemented by adding a T2
prep between the IR preparation and the readout. This
shifted the null time of the myocardium relative to blood
making it possible to choose delays that simultaneously
null both myocardium and blood, with the aim to
achieve a positive contrast between scar and both blood
and normal myocardium. A simplified diagram of the se-
quence timing and illustration of the inversion recovery
is shown in Fig. 1 for bright blood LGE and DB LGE se-
quences. The DB LGE acquisition technique has been
recently described in detail [15]. Briefly, the myocardial
and blood T1 were measured using a long axis T1-
mapping scout scan using the MOdified Look-Locker
Inversion recovery (MOLLI) approach with a modified
protocol using MOCO and a 4s(1s)3s(1s)2s acquisition
scheme that was acquired in 11 s [31]. Blood and myo-
cardial T1 values were measured by the operator and en-
tered on the scanner in the user interface (UI) [15]. The
blood suppression was specified as a fixed default value
(delta) which was darker than the myocardium when the
value delta <0. The sequence calculated preparation de-
lays (TD1, TD2) and T2 preparation echo time (TE) (il-
lustrated in Fig. 1) using a strategy that sought to
achieve the desired blood suppression with the shortest
TE so as to minimize SNR loss.
Respiratory MOCO averaging was used for both bright
blood LGE and DB LGE protocols. The number of aver-
ages was double for the DB LGE protocol as compared
to the bright blood LGE protocol to improve the
contrast-to noise-ratio (CNR) by √2, and thereby miti-
gate the SNR loss due to the T2 weighting. It was previ-
ously shown that by using twice the number of averages
the DB LGE achieved approximately the same SNR [15]
as the bright blood LGE. In order to mitigate through-
plane motion during the free-breathing acquisition (both
bright and DB), 50% of the acquired measurements are
discarded [20]. This strategy has been demonstrated to
work well for both short- and long-axis orientations.
Measurements are discarded based on a mean squared
error similarity criteria.
By choosing the delta parameter less than 0, the blood
becomes negative relative to the myocardium and will
appear blacker when using a phase sensitive reconstruc-
tion [15]. In this case, if the DB LGE image is window
leveled to display the normal myocardium nulled, then
the blood will be displayed darker and there will be no
apparent contrast between the myocardium and adjacent
myocardium. For this reason, the window level is ad-
justed to make the normal myocardium slightly grey
such that the endocardial border with the blood pool is
clearly delineated.
With these protocols (Table 1), a stack of 10 slices
is acquired in 160 heart beats (bright blood) and 320
heart beats (dark blood), corresponding to 2:20 min
and 4:35 min at 70 bpm, respectively. During this
time the gadolinium is clearing, thus the inversion
time to null the normal myocardium is slightly in-
creasing. This would result in a loss of contrast when
using magnitude IR reconstruction requiring contin-
ued readjustment of the inversion time (TI) [26],
however using PSIR, which is insensitive to inversion
time [24] it is not necessary to adjust the TI. This fa-
cilitates scanning the entire stack in a single acquisi-
tion and simplifies the workflow.
The imaging parameters for the DB LGE were saved in
the raw data which was stored for follow-up analysis.
Mean and standard deviation (SD) of the measured T1
for myocardium and blood from the T1-map scout scan
and values for TD1, TD2, and TE calculated by the
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sequence were calculated for all DB LGE scans during
this reporting period.
This bright blood LGE protocol used in this study is
now widely used at a number of institutions. We chose
to compare the DB LGE protocol with 2× averaging (16
vs 8 measurements) in order to match CNR of MI to nor-
mal myocardium [15], as described above. A small sub-
study was conducted (n = 21 subjects) to compare the ef-
fect of averaging and spatial resolution on detectability of
scar. A single slice was imaged using 4 protocols in rapid
succession: a) bright blood LGE with 8 measurements, b)
bright blood LGE with 16 measurements to equal the DB
LGE, c) a higher spatial resolution (288 × 180) bright
blood LGE with 16 measurements (approx. same CNR as
DB LGE), and d) DB LGE with 16 measurements. In cases
for which the MI signal is equal or less than the blood sig-
nal, it was hypothesized that the increased averaging or
spatial resolution would not improve the scar contrast.
CNR was measured between MI and remote, MI and
blood, and blood and remote for all 4 protocols compared.
CNR was measured by difference between measured SNR
values with SNR determined by previously validated SNR
scaled reconstruction which accounted for all parallel im-
aging losses [15, 32].
Image analysis
Image analysis was performed by two independent
observers (RF and TK). The bright blood LGE and DB
Fig. 1 a inversion recovery (IR) for bright blood LGE in case with scar signal (blue) less than blood (red) resulting in poor contrast. b IR for dark blood
(DB) late gadolinium enhancement (LGE) using combined IR and T2 preparation to shift the null time of blood relative to the normal myocardium. In
this case the delays are chosen such that the blood signal (red) is less than the myocardium (dashed grey) resulting in dark blood using phase sensitive
inversion recovery (PSIR) reconstruction, which preserves the signal polarity. Inversion times to null the normal myocardium are depicted by vertical dashed
lines. The loss in signal-to-noise ratio (SNR) due to the T2 preparation is mitigated by increased respiratory motion corrected averaging (MOCO) [15]
Table 1 Imaging protocol parameters
Bright Blood LGE DB LGE
Preparation Inversion
Preparation
Inversion Preparation &
T2 preparation
Readout Single shot, bSSFP
(FAIR = 50°, FA PD = 8°)
Typical FOV / resolution 360 × 270 mm2
1.4 × 1.9 × 8 mm3
Matrix size 256 × 144 (parallel imaging factor 2)
Number of acquired
measurements
8 16
T2 preparation TE 10–40 ms
TE/TR 1.2/2.8 ms
ECG triggering Inversions every 2 RR (HR < 90 bpm)
Inversions every 3 RR (HR > 90 bpm)
DB dark blood, ECG electrocardiom, FOV field-of-view, LGE late gadolinium
enhancement, TE echo time, TR repetition time
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LGE stacks were separated and evaluated in a random
anonymized order using open-source software (Osirix;
the Osirix Foundation, Geneva, Switzerland) [33]. A
qualitative rather than quantitative approach was used
to score the LGE since quantitative methods manually
delineate the blood boundary and are not developed or
validated for dark blood methods.
LGE assessment
The full left ventricular short-axis stack for each tech-
nique was analyzed on a per-segment basis using the
American Heart Association model [34], excluding the
apical cap. Cine images were not available to the ob-
servers but a static 4-chamber image was provided to
allow localization of short axis slices.
The transmural extent of LGE was evaluated using a
three-point Likert score (0, none; 1, <50% wall thickness
LGE; 2, >50% wall thickness LGE). This allowed quanti-
fication of not only how many segments were affected
but using the total from the 16 LV segments, an add-
itional measure of LV ‘scar burden’, with a theoretical
maximum score of 32. In addition, the level of certainty
was rated on a per-segment basis using a binary scale
(confident/non-confident).
Statistical analysis
Statistical analysis was performed using SPSS Statistics
Version 24 (International Business Machines, Armonk,
New York, USA). Inter-observer variability was assessed
by calculating the intraclass correlation coefficient for
each parameter assessed. The chi-square test or Fisher
exact test was used to compare results between both im-
aging techniques. The change in the number of seg-
ments identified using both techniques was analyzed
using a paired t-test.
Each patient was analyzed for the comparison as a sin-
gle data point (each patient had a total score for each
imaging modality going from 0 to a theoretical max-
imum of 16). This approach was used to account for the
fact that segments within the same patient are not inde-
pendent. Statistical significance was defined as p < 0.05.
Results
Of 176 recruited patients, four were excluded from ana-
lysis (Table 2) including three due to poor LGE image
quality (1 bright blood LGE and 2 DB LGE caused by
complete gadolinium washout; these 3 cases had been
allocated to be performed second) and one patient ter-
minated their scan before completion. The remaining
172 patients were analysed using both techniques, corre-
sponding to a total of 2752 LV segments.
Half the patients (n = 86) underwent bright blood LGE
first and the other half underwent sequenced LGE first.
The time following contrast administration for each
stack was comparable across the two groups (Table 3).
Inter-observer agreement and confidence
There was high inter-observer agreement for both se-
quences when determining the presence of LGE as well
as assessing high confidence (Table 4).
Using bright blood LGE, hyperenhancement could be
diagnosed with high confidence in 154/248 regions
(62.1%) and low confidence in the remainder (n = 94/
248; 37.9%). With DB LGE, hyperenhancement was di-
agnosed with high confidence in 275/324 (84.9%) regions
and low confidence in the remainder (n = 49/324;
15.1%); DB LGE allowed a significantly higher propor-
tion of LGE-containing regions to be assigned high con-
fidence (p < 0.05) (Table 5).
Table 2 Baseline characteristics of patient population (n = 172).
Values are n, mean ± standard deviation (SD), or frequency (%)
Age (years) 59 ± 15
Gender (male (%)) 101 (58.7)
Weight (kg) 76 ± 14
Height (cm) 171 ± 10
Body Surface area (m2) 2.0 ± 0.21
Prior myocardial infarction (%) 46 (26.7)
Prior percutaneous coronary intervention (%) 35 (20.3)
Prior coronary artery bypass surgery (%) 6 (3.5)
CMR parameters
LVEDVi, mL/m2 81 ± 26
LVESVi, mL/m2 38 ± 30
SVi, mL/m2 42 ± 12
LAAi, cm2/m2 12 ± 3
RAAi, cm2/m2 11 ± 3
Mitral regurgitation (by CMR)
Not present 134 (77.9%)
Mild 27 (15.7%)
Moderate 9 (5.2%)
Severe 2 (1.2%)
CMR cardiovascular magnetic resonance, LVEDVi left ventricular end-diastolic
volume index, LVESVI left ventricular end-systolic volume index, LAAi left atrial
appendage area index, RAAi right atrial appendage area index, SVI stroke
volume index
Table 3 Average (mean ± standard deviation (SD)) time of
initiating each short axis stack, recorded as minutes and seconds
after administration of gadolinium. Patients were split into two
equal groups, one undergoing bright blood LGE first, the other
undergoing DB LGE first
Bright blood LGE first DB LGE first
Time of first stack (min:sec) 09:04 (±3:26) 09:49 (±3:06)
Time of second stack (min:sec) 16:33 (±3:47) 16:00 (±3.48)
DB dark blood, LGE late gadolinium enhancement
Francis et al. Journal of Cardiovascular Magnetic Resonance  (2017) 19:91 Page 5 of 12
LGE in LV segments
DB LGE identified significantly more areas of hyperen-
hancement than bright blood LGE (Figs. 1 and 2). DB
LGE analysis found 41.5% more segments that exhibited
LGE in comparison to bright blood LGE (248/2752 seg-
ments (9.0%) positive for hyperenhancement with bright
blood; 351/2752 segments (12.8%) positive for LGE with
DB LGE; p < 0.05).
On a per-patient basis, bright blood LGE identified
definite (high confidence) hyperenhancement in 58 pa-
tients, whereas the DB LGE allowed detection of hyper-
enhancement in 81 patients. The average total
hyperenhancement burden per patient was scored 31.8%
higher using DB LGE. Eighteen patients assessed to have
no hyperenhancement with bright blood LGE were
found to have hyperenhancement using DB LGE. Of
these, 15 did not have a past history of MI, 4 of whom
had been admitted with a troponin-positive acute coron-
ary event but had no significant coronary artery disease
on invasive angiography.
The majority of segments containing hyperenhance-
ment identified by either sequence were subendocar-
dially distributed, however some patients exhibited mid-
wall and epicardial hyperenhancement. Epicardial hyper-
enhancement was seen in 5/2752 segments using both
techniques. Mid-wall hyperenhancement was seen in 9/
2752 segments with bright blood LGE and 6/2752 using
the DB LGE.
Eleven patients (23 segments) assessed to have low
confidence scar with bright blood LGE were found to be
free of hyperenhancement on DB LGE. Thirteen patients
(33 segments) assessed as demonstrating at least one
segment of <50% wall thickness hyperenhancement were
upgraded to >50% with DB LGE. A total of 103 seg-
ments were reclassified from normal to showing scar, all
of which was subendocardial in distribution. However, 3
patients with definite (high confidence) hyperenhance-
ment on bright blood failed to show hyperenhancement
on DB LGE, all of whom had non-sub-endocardial
hyperenhancement distribution.
LGE in the papillary muscles
Using bright blood LGE, only 5 patients were thought to
have hyperenhancement in either papillary muscle, how-
ever with DB LGE, 33 patients (19%) were identified
with papillary muscle hyperenhancement (Fig. 3). Of
these, 9 had infarcted myocardium in segments adjacent
to the affected papillary muscle but the remaining 26 ap-
peared to have isolated papillary muscle hyperenhance-
ment. Overall, there was no significant correlation to
presence of papillary muscle LGE with mitral regurgita-
tion severity nor indexed left atrial area (LAA) (Fig. 4).
User parameters
The measured myocardial and blood T1 measured using
the MOLLI scout prior to the DB LGE and entered as
parameters to the sequence user interface were 505 ±
61 ms (mean ± SD) and 377 ± 65 ms, respectively. The
values of derived parameters calculated by the sequence
were: TE = 18.7 ± 6.2 ms, TD1 = 43.7 ± 30.2 ms, and
TD2 = 60.4 ± 35.9 ms.
Increased averaging
A sub-study examining the effect of averaging confirmed
that increased averaging did not improve the apparent
contrast of bright blood LGE in cases with poor blood
pool contrast. Twenty-one patients were imaged, that
were positive for LGE.
The CNR between the MI and adjacent blood pool
was: 6.2 ± 10.5, 7.3 ± 14.0, 4.3 ± 8.7, and 26.3 ± 10.7
(mean ± SD), for bright blood LGE with 8 avg. (average),
bright blood LGE with 16 avg., high resolution bright
blood LGE with 16 avg., and DB LGEwith 16 avg.,
respectively. The CNR between the MI and remote myo-
cardium was: 21.0 ± 10.7, 28.1 ± 16.2, 14.6 ± 9.5, and
17.9 ± 10.0 (mean ± SD), for bright blood LGE with 8
avg., bright blood LGE with 16 avg., high resolution
bright blood LGE with 16 avg., and DB LGE with 16 avg.
respectively.
The CNR for the DB LGE with 16 averages for this
group was 15% less than the bright blood LGEusing 8
averages which is consistent with previous measure-
ments [15]. The CNR between the remote myocardium
and adjacent blood pool was: −14.8 ± 9.3, −20.8 ± 13.8,
−10.3 ± 6.2, and +8.4 ± 5.9 (mean ± SD), for bright blood
LGE with 8 avg., bright blood with 16 avg., high reso-
lution bright blood LGE with 16 average, and DB LGE
Table 4 Inter-observer agreement for presence of LGE (number
of segments showing LGE) and high LGE diagnostic confidence,
for both bright blood and DB sequences
Bright Blood LGE DB LGE
ICC ICC
Presence of LGE 0.88 (0.84–0.91) 0.92 (0.89–0.94)
High confidence LGE 0.75 (0.70–0.81) 0.89 (0.86–0.92)
Table 5 Comparison of LV LGE detection, transmurality,
diagnostic confidence and mean LGE burden between bright
blood and DB imaging techniques
Bright Blood LGE DB LGE
Segments with LGE 248/2752 (9.0%) 351/2752 (12.8%)
> 50% transmurality 126 (50.8%) 169 (48.1%)
< 50% transmurality 122 (49.2%) 182 (51.9%)
LGE with high confidence 154/248 (62.1%) 302/351 (86.0%)
LGE with low confidence 94/248 (37.9%) 49/351 (14.0%)
Average LV LGE burden 2.23 2.94
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with 16 avg. respectively, providing positive contrast for
the remote myocardium.
Discussion
This prospective study shows that a dark blood LGE
with MOCO approach can be implemented into a clin-
ical workflow. It requires the acquisition of a single T1
map used to measure T1 blood and myocardium. The
total time for the T1 map and the left ventricular short
axis stack is approximately 4 min depending on the
heart rate. The DB LGE detects more hyperenhance-
ment overall, particularly subendocardial hyperenhance-
ment. In 9% of patients, DB LGE detected missed
infarcts that are likely of high clinical importance. We
also show that clinicians found the DB LGE easier to in-
terpret and that interpretations are associated with
higher confidence.
Fifteen patients without a known MI diagnosis were
declared free of any scar using bright blood LGE, but ac-
tually had subendocardial hyperenhancement on DB
LGE. There is potential that this approach could lead to
significant change in patient management. Four of these
patients found to have hyperenhancement with only DB
LGE had been admitted acutely for an acute coronary
syndrome but had unobstructed coronary arteries on
invasive angiography. A meta-analysis of patients with
MI with non-obstructed coronary arteries showed that
typical CMR features of infarct hyperenhancement are
only seen in 24% of cases and no significant abnormality
in 26% [35]. It is possible that some patients currently
deemed free of MI on conventional bright blood LGE
may in fact have typical subendocardial hyperenhance-
ment caused by MI and should receive secondary pre-
vention therapies. The other 11 patients out of the 15
with DB LGE but negative bright blood images were
non-urgent patients referred for CMR for a variety of
reasons. One patient was undergoing a surveillance
CMR for hypertrophic cardiomyopathy and had never
been diagnosed with any hyperenhancement previously,
yet DB LGE revealed hyperenhancement, which may
have prognostic relevance.
A major difference between the sequences is the marked
difference in apparent papillary muscle hyperenhance-
ment. Papillary muscles are comparatively small and sur-
rounded by blood so normally very hard to distinguish
hyperenhancement on conventional bright blood LGE,
but more easily visible on DB LGE. Care was taken to
avoid diagnosing papillary muscle hyperenhancement on a
short-axis slice selected too close to the base as fibrous
structures such as chordae enhance brightly. Aside from 9
patients who had papillary muscle LGE in association with
a MI (5 inferior, 4 anterior), the majority of the additional
patients found to have hyperenhancement using the DB
LGE had enhancement limited to a papillary muscle. As
papillary muscle hyperenhancement is rarely so easily
seen, the clinical significance of isolated papillary muscle
hyperenhancement is unclear. Studies examining the rele-
vance of papillary muscle hyperenhancement on bright
blood LGE have found 14% of patients with confirmed
ST-segment elevation MIs (STEMIs) display papillary
muscle hyperenhancement and that there is an association
with mitral regurgitation [36]. In our cohort of 121
patients, we recorded 19.2% as positive for papillary
muscle hyperenhancement on DB LGE and found no cor-
relation with mitral regurgitation and indexed LAA, how-
ever only 11 patients had significant mitral regurgitation,
so further investigation would be warranted. If the appear-
ances are consistent with true LGE, these findings might
Fig. 2 Total number of left ventricular (LV) segments identified (left) and diagnostic confidence when diagnosing late gadolinium enhancement (LGE)
(right) using both bright blood and dark blood (DB) imaging. The time after gadolinium administration is recorded for each sequence (minutes:seconds)
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suggest some degree of papillary muscle hyperenhance-
ment is within normal limits and simply not previously
detected with bright blood LGE.
In this paper a qualitative approach was used for scar
detection. Although there are published methods for
quantitative measurement of size, there is no consensus
on these methods, moreover most are not widely
available. Most importantly these methods have been de-
veloped for bright blood LGE and have not been tested
on images obtained using a DB LGE.
Quantifying infarct size involves several challenges.
One is detecting the subendocardial border and another
is determining which myocardial pixels are scar. The
current tools address the latter, either by setting a
Fig. 3 Consecutive short axis slices from four patients. In each panel, bright blood late gadolinium enhancement (LGE) sequences appear above
dark blood (DB) LGE. The time after gadolinium administration is recorded for each sequence (minutes:seconds). Patient A: DB LGE reveals a
large left anterior descending (LAD) territory infarct, the size and borders of which are not clearly delineated on bright blood imaging. Bright
blood 14:43, DB 21:21. Patient B: Inferior infarction can be seen on the bright blood images but it is difficult to appreciate if the basal slice is
affected or to see the endomyocardial border at all. DB images reveal segments showing LGE and the myocardial structure. Bright blood 10:31, DB 16:07.
Patient C: Bright blood images suggest anterior LGE but it is difficult to quantify accurately. DB LGE shows the extent of an anterior infarct. Bright blood
8:13, DB 16:14. Patient D: Poor contrast between scar and the blood pool masks antero-lateral scar, seen easily with DB LGE. Bright 6:59, DB 12:12
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threshold relative to the noise (a fixed number of stand-
ard deviations) or using a full width half max (FWHM)
to mitigate partial volume blurring. However, the pub-
lished methods rely on manually traced endocardial bor-
ders. In cases with poor infarct-blood contrast, the
subendocardial border is particularly difficult to meas-
ure. This demonstrates that the largest source of error in
quantifying scar size will be this manually traced border.
This is an area deserving of a study but is outside the
scope of our current manuscript.
Some preliminary studies have used alternative
methods to produce a dark blood pool and showed that
these sequences are helpful for improved delineation of
subendocardial infarction, particularly when the T1
values for enhancing myocardium and ventricular blood
are similar, which is frequently the case. [10, 11] [12–
14]. In this prospective study we use a new DB LGE
approach in a relatively large patient cohort and per-
formed a comparison with whole heart coverage
between standard bright blood LGE images and novel
DB LGE images. Furthermore, combining a PSIR-T2
preparation with a single shot bSSFP readout and
respiratory motion corrected averaging [16, 20, 21],
imaging acquisition is conducted free-breathing,
which has benefits for image quality, patient comfort,
and clinical workflow [15].
The use of cine images in conjunction with late en-
hancement images has been cited as a means of address-
ing the issue of subendocardial MI cases with low
contrast between the MI and blood pool [26]. Cine im-
ages offer excellent resolution and contrast between
blood and myocardium, and this technique is often very
helpful, although it is sometimes time-consuming to
interpret the results due to differences in spatial and
temporal resolution. It is also noted that cine and LGE
images are acquired at different times and may have dif-
ferent slice positions, even though the slice prescription
is the same, due to differences in respiratory position.
Even small differences may complicate the interpretation
or make it impossible to resolve, since the subendocar-
dial MI may be very narrow or small. The accuracy of
the subendocardial border will affect the assessment of
transmurality, an important prognostic indicator. This is
not to imply that cine imaging is not useful or that one
should not use all available data to achieve the best in-
terpretation, but rather to stress potential pitfalls. The
proposed DB LGE method provides an easy means of
enhanced detection.
Fig. 4 Paired SA slices from 3 patients showing papillary muscle late gadolinium enhancement (LGE). In the top left corner of each image is the
time after administration of gadolinium (minutes:seconds)
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The DB LGE technique is robust in that it is fairly in-
sensitive to the measured T1’s entered as input parameters
[15]. By virtue of using PSIR reconstruction, errors in the
measured myocardial T1 results in an imperfect null, which
may be adjusted by window-level in the displayed PSIR
image. Errors in the blood T1 result in a different degree of
blood suppression. The current protocol sets the blood to
be less than the myocardium thus appearing blacker in the
PSIR image, and the parameter is set for adequate contrast
so that typical variations are not noticeable.
Both the non-selective double IR, the IR-T2 and MT
preparations achieve a large degree of flow independence.
In the case of the IR-T2 approach, the blood suppression
will depend on the T2 thus blood oxygenation will cause
difference in blood between the LV and RV. The MT
preparation is independent of T2 but will depend on the
effective B1 (transmit flip angle) which will vary across the
heart. The myocardial T2 is well characterized and there-
fore SNR losses due to T2 preparation may be predicted
and compensated for by averaging. The myocardial signal
loss due to MT is less well characterized, thus the per-
formance is less well characterized. Similarly, methods
that rely strictly on T1 differences are difficult to predict
performance since there are wide variations in gadolinium
concentrations due to a variety of mechanisms and timing
which is difficult to control in a clinical environment.
Limitations
We found increased LGE detection with DB LGE. We also
noticed an increase in observer confidence, particularly
for subendocardial hyperenhancement. Whilst the authors
feel this to be related to improved scar detection, there
was no histologic confirmation. Future studies validating
histologically these findings would be of great value.
DB LGE acquisition is prolonged as compared with
bright blood LGE due to the increased number of mea-
surements (16 vs 8). In our experience, a full left
ventricular short axis stack required approximately 4 min.
However, due to the fact the sequences are free-breathing,
this does not significantly impact on patient comfort. A
single gadolinium dose was examined. Single dose and 1.5
dose gadolinium is often cited and shown to provide ex-
cellent quality [26] although the original protocols used in
widely cited validation experiments [25] used triple dose.
Recent validation has been performed for 1.5 dose [37]
whilst no validation studies are available for single dose in
terms of a histological reference standard. There are re-
cent dose comparison studies that indicate that single
dose is a effective for LGE [28, 30]. The time from gado-
linium injection for LGE imaging was described in the ori-
ginal LGE validation paper [25] at about 20 min for
accurately delineating scar. In the present paper an 8–
15 min window was selected. This is the result of the
Fig. 5 Examples of 4 patients that underwent bright blood late gadolinium enhancement (LGE) first and dark blood (DB) LGE second (left column)
and 4 additional patients that underwent the sequences in the opposite order (right column). The bright blood LGE, for either acquisition order,
exhibits a range of contrast between the subendocardial scar and adjacent blood pool, from good (top rows) to poor (bottom rows) contrast, whereas
the DB LGE had excellent contrast in all cases. In the top left corner of each image is the time after administration of gadolinium (minutes:seconds)
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single gadolinium dose and is in line with the T1 mapping
guidelines for extracellular volume mapping currently [31,
38]. These guidelines for mapping are believed to be
broadly relevant to imaging fibrosis since the mechanism
of gadolinium distribution dictates the LGE contrast. The
DB LGE approach requires manual entry of myocardial
and blood pool T1 in sequence UI [15], which are derived
from a single post-contrast MOLLI map. DB LGE does re-
quire more manual windowing prior to analysis than
bright blood LGE, but again this is straightforward after a
small amount of practice. An appropriately windowed DB
LGE image produces a black blood pool, dark grey myo-
cardium and white gadolinium enhancement. Examples of
patients undergoing bright blood LGE before DB LGE and
vice versa are shown in Fig. 5.
Mid-wall, epicardial and right ventricular LGE diagnoses
were noted in some patients, but the small numbers do
not allow conclusions to be drawn and this represents an
important area of further investigation. Given these limita-
tions, at present DB LGE approach should be considered
not as replacement for conventional LGE, but providing
considerable added value. Further work is needed to ex-
plore the clinical role in different patient cohorts including
both ischemic and non ischemic aetiologies.
Conclusion
DB LGE is a novel technique to improve LGE detection
by nulling the blood pool. DB LGE detects more areas of
subendocardial hyperenhancement than conventional
bright blood LGE and allows a much higher level of confi-
dence when deciding if a region of myocardium exhibits
any scar. It is likely to be of greatest use when looking for
hyperenhancement at the endomyocardial-blood border
and thus may be of particular use in patients with sus-
pected or proven ischemic heart disease.
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